This inventor holds 1 USPTO granted patent. Top assignees: The Hong Kong Polytechnic University, University of Macau. Active years: 2016.
Company Filing History:
1 out of 438 
1 out of 77 
Years Active: 2016
Title: Innovations of Chung Lit Choi in Neuro-Protective Drugs
Introduction
Chung Lit Choi is a notable inventor based in Hong Kong, CN. He has made significant contributions to the field of neuro-protective drugs, particularly in the treatment of neurodegenerative diseases. His innovative approach focuses on the use of indole-ketones and indolidones to combat conditions such as Parkinson's disease.
Latest Patents
Choi holds a patent for the "Uses of indole-ketones or indolidones as neuro-protective drugs." This invention outlines a method for utilizing compounds like SU4312, SU5416, SU11248 (Sunitinib), and indirubin-3-oxime to treat neurodegenerative diseases associated with excessive neuronal Nitric Oxide Synthase (nNOS) activity. He has 1 patent to his name, showcasing his innovative contributions to medical science.
Career Highlights
Throughout his career, Chung Lit Choi has worked with prestigious institutions such as the University of Macau and The Hong Kong Polytechnic University. His work in these academic environments has allowed him to collaborate with other researchers and contribute to advancements in neuro-protective therapies.
Collaborations
Choi has collaborated with notable colleagues, including Ming Yuen Lee and Yifan Han. These partnerships have further enriched his research and development efforts in the field of neuro-protective drugs.
Conclusion
Chung Lit Choi's innovative work in the realm of neuro-protective drugs highlights his commitment to addressing critical health challenges. His patent and collaborations reflect his significant impact on medical research and the potential for future advancements in treating neurodegenerative diseases.